Skip to content

A randomized controlled study of floating needle in the treatment of knee osteoarthritis

A randomized controlled study of floating needle in the treatment of knee osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006055
Enrollment
Unknown
Registered
2022-06-03
Start date
2022-05-24
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Treatment group:Floating needle
Control group:Rehabilitation technique

Sponsors

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Those who meet the diagnostic criteria of the American rheumatic Society for knee arthritis and are confirmed by X-ray films; (2) Grade I, II and III patients meeting the radiological diagnostic criteria of Kellgren lawrecne; (3) Between 40-80 years old, regardless of gender; (4) Those who have not taken other relevant drugs or adopted relevant treatment methods within 1 week (those who have taken drugs for a long time need to stop taking drugs for 1 week before they can be included in the observation); (5) Volunteer to participate, sign the informed consent form, and be willing to accept the test.

Exclusion criteria

Exclusion criteria: (1) Pregnant women or persons suffering from major diseases or infectious diseases; (2) Patients with a history of fracture, dislocation, tuberculosis, tumor, infection, etc. in the knee joint (the condition of such patients may affect the observed treatment results); (3) Those who are allergic to the medical devices (such as floating needles) involved in this test; (4) Mental illness, lack of self-control, unable to express accurately; (5) Those who participated in other clinical trials 3 months before the trial; (6) The educational level is too low to understand the contents of the test or scale.

Design outcomes

Primary

MeasureTime frame
WOMAC Osteoarthritis Index;

Secondary

MeasureTime frame
Three dimensional gait;X-ray;Musculoskeletal ultrasound;VAS score;

Countries

China

Contacts

Public ContactJun He
895150145@qq.com13728020800

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026